... to the pages of Key Opinions in Medicine (KOM) KOM is a newsletter service delivered by Wiley-Blackwell to update healthcare professionals on new developments across various therapy areas.

KOM began its life with Dermatology and Hematology, but we are constantly trying to broaden our spectrum and grow. We are looking forward to interaction with our readers so please feel free to send questions and comments to us.

Latest Issues

2015 issue 13 Urticaria

Chronic urticaria (CU) is a skin disease, characterized by the presence of wheals (hives) and/or angioedema, which last up to 24 hours and reoccur over a period of at least 6 weeks. CU is classified as chronic spontaneous urticaria / chronic idiopathic urticaria (CSU / CIU) or chronic inducible urticaria (CINDU).

Topic: Dermatology issue: 13/2015

2015 Issue 04 house dust mite respiratory allergic disease

This meeting report provides you with highlights of a recent company-sponsored symposium, 'Integrated management of house dust mite respiratory allergy', held on 8 June 2015 during the 34th EAACI congress in Barcelona, Spain. It signalled the need for a more integrated treatment approach to house dust mite respiratory allergic disease.

Topic: Allergy and Immunology issue: 4/2015

2015 issue 12 Plaque-Psoriasis bei Kindern

Die Europäische Kommission hat Stelara® (Ustekinumab) für die Behandlung der mittelschweren bis schweren Plaque-Psoriasis bei Kindern und Jugendlichen ab 12 Jahren zugelassen, die unzureichend auf andere systemische Therapien oder Phototherapien angesprochen oder sie nicht vertragen haben. Ustekinumab ist das erste Biologikum

mit einem alternativen Wirkmechanismus zu den Tumor-Nekrosefaktor (TNF)-α-Inhibitoren, das nun auch für die Behandlung dieser Patientengruppe zugelassen ist.

Topic: Dermatology issue: 12/2015

2015 issue 03 Asthma and chronic spontaneous urticaria

This issue focuses on the role of Immunoglobulin E (IgE) in severe allergic asthma and chronic spontaneous urticaria / chronic idiopathic urticaria (CSU / CIU, hereafter CSU) and treatment of these diseases with anti-IgE therapy as based on clinical trial programs and further supported by real world experience as described in patient cases.

The present newsletter provides you with highlights of a satellite symposium during the European Academy of Allergy and Clinical Immunology (EAACI) yearly meeting in Barcelona, Spain (June 2015).

The symposium was entitled: “Back to the future: the IgE journey in asthma, chronic spontaneous urticaria and beyond” and featured Professor Ana M. Giménez-Arnau, Professor Stephen Holgate, Professor Eugene Bleecker, and Professor Thomas Casale providing expert insights.

Topic: Allergy and Immunology issue: 3/2015

2015 issue 11 Melanomtherapie

In der Therapie des fortgeschrittenen Melanoms hat es über Jahre keine signifikanten Fortschritte gegeben. Mit der Immunonkologie, die das körpereigne Immunsystem zur Krebsbekämpfung nutzt, und der Entwicklung von spezifischen Antikörpern, die gezielt in Immun-Checkpoint-Signalwege eingreifen, hat sich die Situation grundlegend verändert.

Topic: Dermatology issue: 11/2015


KOM is an international publication that can appear in different languages. We offer our sponsors the option to publish across multiple languages or choose one. Please let us know when you need an issue in another language than the one shown.